4//SEC Filing
Sullivan Lara 4
Accession 0000950170-24-139616
CIK 0001782223other
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 4:33 PM ET
Size
5.3 KB
Accession
0000950170-24-139616
Insider Transaction Report
Form 4
Sullivan Lara
DirectorPresident ,CEO & CMO
Transactions
- Award
Stock Option (Right to Buy)
2024-12-23+1,135,000→ 1,135,000 totalExercise: $1.67Exp: 2034-12-23→ Common Stock (1,135,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option vest in full on December 23, 2025, subject to the Reporting Person's continued employment through the vesting date.
Documents
Issuer
Pyxis Oncology, Inc.
CIK 0001782223
Entity typeother
Related Parties
1- filerCIK 0001769457
Filing Metadata
- Form type
- 4
- Filed
- Dec 22, 7:00 PM ET
- Accepted
- Dec 23, 4:33 PM ET
- Size
- 5.3 KB